The report is titled ‘Leadless Pacemakers Market: Opportunity Analysis and Future Assessment 2020-2028’. An overview of conceptual frameworks, analytical approaches of the leadless pacemakers market is the main objective of the report, which further consists of the market opportunity and insights of the data involved in the making of the respective market. Leadless pacemakers market is expected to grow at a significant rate in the near future.
The global leadless pacemakers market in 2020 is estimated for more than US$ 31.3 Mn and expected to reach a value of US$ 69.9 Mn by 2028 with a significant CAGR of 10.6%.
Leadless Pacemakers Market Definition
A medical device that assists a person’s heartbeat more regularly is known as the pacemaker. The artificial cardiac pacemaker is a tiny medical device placed in the chest of the patient through a surgical procedure in order to regulate the heartbeat of the person if it is slower or irregular than usual.
Basically, the artificial cardiac pacemaker provokes electrical impulses conveyed by electrodes in order to contract the heart muscle chambers and thereby pump blood. The pacemaker regulates and/or replaces the function of the electrical conduction system of the heart.
Further, leadless pacemakers have been recently introduced to the global market with some of the most essential benefits as well as few drawbacks. Primarily, the leadless pacemaker is much tinier than the usual transvenous pacemaker and more importantly, it can be put into the patient’s chest without any surgery as it is implanted through a femoral vein transcatheter approach. Owing to such benefits, the leadless pacemakers are projected to witness huge demand in the global market in the forthcoming years.
Leadless Pacemakers Market Dynamics
The constantly increasing count of patients suffering from cardiovascular ailments and other heart-related problems, particularly arrhythmias, across the world is one of the major drivers projected to give a positive push to the growth of the global leadless pacemaker market in the near future.
By the same token, a huge upsurge in the geriatric population all across the world, as well as the sluggish lifestyle of the population with desk-bound jobs and unhealthy diets, is also contributing to the growing count of heart patients worldwide, thereby elevating the demand for leadless pacemakers in the near future. Therefore, the global leadless pacemaker market is projected to observe rapid growth during the forecast period.
Along with that, the leadless pacemaker is way smaller than the usual pacemaker and it requires no chest incision for the implantation, which further stimulates its demand over usual transvenous pacemakers. Attributing to such factors, the global leadless pacemaker market is expected to observe a breakthrough in the near future.
Furthermore, the leadless pacemaker is a self-sufficient generator and electrode system embedded directly into the right ventricle along with the absence of leads thus eradicating potential lead and pacemaker pocket related complications, hence the global leadless pacemaker market is expected to flourish swiftly in the coming years.
However, there are also some restraining factors such as stringent regulatory approvals, the huge cost of the product, and lack of experienced operators, and battery exhaustion issues, which may refrain the growth of the global leadless pacemaker market during the forecast timeframe.
Leadless Pacemakers Market Segmentation
The Leadless Pacemakers market is segmented on the basis of indication, technology, end-user, and by region.
On the basis of indication, the leadless pacemakers market is segmented into
• Atrial Fibrillation
• High Degree Atrioventricular Block
• Sinus node dysfunction
On the basis of technology, the market is segmented into
• Micra Transcatheter Pacing System
• Nanostim Leadless Pacemakers
• Wireless Cardiac Simulation System
On the basis of End User, the market is segmented into
• Hospitals
• Catheterization Laboratories
On the basis of Region, the leadless pacemakers market is segmented into
• North America (U.S., Canada)
• Latin America (Brazil, Mexico, Argentina, Rest of Latin America)
• Europe (U.K., Germany, Italy, France, Spain, Russia, Poland, BENELUX, NORDIC)
• Asia Pacific (China, India, Japan, Australia and New Zealand, South Korea, ASEAN, Rest of Asia)
• Middle East (GCC Countries, Israel, Oman, Rest of Middle East)
• Africa (South Africa, Egypt, North Africa, Rest of Africa)
Leadless Pacemakers Market Key Players
Some of the key participating players in the leadless pacemakers market are Medtronic, St. Jude Medical LLC, Biotronic, Boston Scientific, Edwards Lifesciences, Sorin Group, Vitatron, Lepu Medical, and Terumo Corp.
MMC Overview on Leadless Pacemakers Market Report
The non-identical approach of Meridian Market Consultants stands with conceptual methods backed up with the data analysis. The novel market understanding approach makes up the standard of the assessment results that give a better opportunity for the customers to put their effort.
A research report on the Leadless Pacemakers market by Meridian Market Consultants is an in-depth and extensive study of the market based on the necessary data crunching and statistical analysis. It provides a brief view of the dynamics flowing through the market, which includes the factors that support the market and the factors that are acting as impedance for the growth of the market.
Furthermore, the report includes the various trends and opportunities in the respective market in different regions for a better understanding of readers that helps to analyze the potential of the market.
Factors that are benchmarked while estimating the market
Various factors that are benchmarked while estimating the market growth include (but not restricted to):
• New product designs and launches
• Current product compliance
• Reimbursement
• Concerns for use of Leadless Pacemakers
• Advantages of Leadless Pacemakers
Actions taken by the manufacturer and respective regulatory authorities also impact the market growth of the segment. These factors are understood at a regional level and in major countries globally for providing regional insights of the product segment in the report. This helps our clients to make an informed decision.
A mix of top-down and bottom-up approach is followed to arrive at and validate our market value estimations. For a product segment wherein one/two manufacturer(s) dominates the market, its product sales, previous growth rates, and market expansion plans are considered to generate market share in the global market.
1. Global Leadless Pacemakers Market Report Overview
1.1. Introduction
1.2. Report Description
1.3. Methodology
2. Global Leadless Pacemakers Market Overview
2.1. Introduction
2.1.1. Market Definition
2.1.2. Market Taxonomy
2.2. Executive Summary
2.3. Global Leadless Pacemakers Market Snapshot
2.4. Global Leadless Pacemakers Market Size and Forecast, 2020–2028
2.4.1. Introduction
2.4.2. Market Value Forecast and Annual Growth Rate (AGR) Comparison (2020–2028)
2.5. Global Leadless Pacemakers Market Dynamics
2.5.1. Drivers
2.5.2. Restraints
2.5.3. Opportunity
2.5.4. Trends
2.6. Key Regulations
2.7. Porter’s Five Forces Model
3. Global Leadless Pacemakers Market, By Indication
3.1. Introduction
3.1.1. Annual Growth Rate Comparison, By Indication
3.1.2. BPS Analysis, By Indication
3.2. Market Revenue (US$Mn) Forecast, By Indication
3.2.1. Atrial Fibrillation
3.2.2. High Degree Atrioventricular Block
3.2.3. Sinus node dysfunction
3.3. Global Leadless Pacemakers Market Attractiveness Index, By Indication
4. Global Leadless Pacemakers Market, By Technology
4.1. Introduction
4.1.1. Annual Growth Rate Comparison, By Technology
4.1.2. BPS Analysis, By Technology
4.2. Market Revenue (US$Mn) Forecast, By Technology
4.2.1. Micra Transcatheter Pacing System
4.2.2. Nanostim Leadless Pacemakers
4.2.3. Wireless Cardiac Simulation System
4.3. Global Leadless Pacemakers Market Attractiveness Index, By Technology
5. Global Leadless Pacemakers Market, By End User
5.1. Introduction
5.1.1. Annual Growth Rate Comparison, By End User
5.1.2. BPS Analysis, By End User
5.2. Market Revenue (US$Mn) Forecast, By End User
5.2.1. Hospitals
5.2.2. Catheterization Laboratories
5.3. Global Leadless Pacemakers Market Attractiveness Index, By End User
6. Global Leadless Pacemakers Market, By Region
6.1. Introduction
6.1.1. Annual Growth Rate Comparison, By Region
6.1.2. BPS Analysis, By Region
6.2. Market Revenue (US$Mn) Forecast, By Region
6.2.1. North America
6.2.2. Latin America
6.2.3. Europe
6.2.4. Asia Pacific
6.2.5. Middle East
6.2.6. Africa
6.3. Global Leadless Pacemakers Market Attractiveness Index, By Region
7. North America Leadless Pacemakers Market Analysis and Forecast, 2020–2028
7.1. Introduction
7.1.1. Annual Growth Rate Comparison, By Country
7.1.2. BPS Analysis, By Country
7.2. Market Revenue (US$Mn) Forecast, By Country
7.2.1. U.S. Leadless Pacemakers Market
7.2.2. Canada Leadless Pacemakers Market
7.3. North America Leadless Pacemakers Market, By Indication
7.3.1. Atrial Fibrillation
7.3.2. High Degree Atrioventricular Block
7.3.3. Sinus node dysfunction
7.4. North America Leadless Pacemakers Market, By Technology
7.4.1. Micra Transcatheter Pacing System
7.4.2. Nanostim Leadless Pacemakers
7.4.3. Wireless Cardiac Simulation System
7.5. North America Leadless Pacemakers Market, By End User
7.5.1. Hospitals
7.5.2. Catheterization Laboratories
7.6. North America Leadless Pacemakers Market Attractiveness Index
7.6.1. By Country
7.6.2. By Indication
7.6.3. By Technology
7.6.4. By End User
8. Latin America Leadless Pacemakers Market Analysis and Forecast, 2020–2028
8.1. Introduction
8.1.1. Annual Growth Rate Comparison, By Country
8.1.2. BPS Analysis, By Country
8.2. Market (US$Mn) Forecast, By Country
8.2.1. Brazil Leadless Pacemakers Market
8.2.2. Mexico Leadless Pacemakers Market
8.2.3. Argentina Leadless Pacemakers Market
8.2.4. Rest of Latin America Leadless Pacemakers Market
8.3. Latin America Leadless Pacemakers Market, By Indication
8.3.1. Atrial Fibrillation
8.3.2. High Degree Atrioventricular Block
8.3.3. Sinus node dysfunction
8.4. Latin America Leadless Pacemakers Market, By Technology
8.4.1. Micra Transcatheter Pacing System
8.4.2. Nanostim Leadless Pacemakers
8.4.3. Wireless Cardiac Simulation System
8.5. Latin America Leadless Pacemakers Market, By End User
8.5.1. Hospitals
8.5.2. Catheterization Laboratories
8.6. Latin America Leadless Pacemakers Market Attractiveness Index
8.6.1. By Country
8.6.2. By Indication
8.6.3. By Technology
8.6.4. By End User
9. Europe Leadless Pacemakers Market Analysis and Forecast, 2020–2028
9.1. Introduction
9.1.1. Annual Growth Rate Comparison, By Country
9.1.2. BPS Analysis, By Country
9.2. Market (US$Mn) Forecast, By Country
9.2.1. U.K. Leadless Pacemakers Market
9.2.2. Germany Leadless Pacemakers Market
9.2.3. Italy Leadless Pacemakers Market
9.2.4. France Leadless Pacemakers Market
9.2.5. Spain Leadless Pacemakers Market
9.2.6. Russia Leadless Pacemakers Market
9.2.7. Poland Leadless Pacemakers Market
9.2.8. BENELUX Leadless Pacemakers Market
9.2.9. NORDIC Leadless Pacemakers Market
9.2.10. Rest of Europe Leadless Pacemakers Market
9.3. Europe Leadless Pacemakers Market, By Indication
9.3.1. Atrial Fibrillation
9.3.2. High Degree Atrioventricular Block
9.3.3. Sinus node dysfunction
9.4. Europe Leadless Pacemakers Market, By Technology
9.4.1. Micra Transcatheter Pacing System
9.4.2. Nanostim Leadless Pacemakers
9.4.3. Wireless Cardiac Simulation System
9.5. Europe Leadless Pacemakers Market, By End User
9.5.1. Hospitals
9.5.2. Catheterization Laboratories
9.6. Europe Leadless Pacemakers Market Attractiveness Index
9.6.1. By Country
9.6.2. By Indication
9.6.3. By Technology
9.6.4. By End User
10. Asia Pacific Leadless Pacemakers Market Analysis and Forecast, 2020–2028
10.1. Introduction
10.1.1. Annual Growth Rate Comparison, By Country
10.1.2. BPS Analysis, By Country
10.2. Market (US$Mn) Forecast, By Country
10.2.1. China Leadless Pacemakers Market
10.2.2. India Leadless Pacemakers Market
10.2.3. Japan Leadless Pacemakers Market
10.2.4. Australia and New Zealand Leadless Pacemakers Market
10.2.5. South Korea Leadless Pacemakers Market
10.2.6. ASEAN Leadless Pacemakers Market
10.2.7. Rest of Asia Pacific Leadless Pacemakers Market
10.3. Asia Pacific Leadless Pacemakers Market, By Indication
10.3.1. Atrial Fibrillation
10.3.2. High Degree Atrioventricular Block
10.3.3. Sinus node dysfunction
10.4. Asia Pacific Leadless Pacemakers Market, By Technology
10.4.1. Micra Transcatheter Pacing System
10.4.2. Nanostim Leadless Pacemakers
10.4.3. Wireless Cardiac Simulation System
10.5. Asia Pacific Leadless Pacemakers Market, By End User
10.5.1. Hospitals
10.5.2. Catheterization Laboratories
10.6. Asia Pacific Leadless Pacemakers Market Attractiveness Index
10.6.1. By Country
10.6.2. By Indication
10.6.3. By Technology
10.6.4. By End User
11. Middle East Leadless Pacemakers Market, By Region
11.1. Introduction
11.1.1. Annual Growth Rate Comparison, By Country
11.1.2. BPS Analysis, By Country
11.2. Market (US$Mn) Forecast, By Country
11.2.1. GCC Countries Leadless Pacemakers Market
11.2.2. Israel Leadless Pacemakers Market
11.2.3. Oman Leadless Pacemakers Market
11.2.4. Rest of Middle East Leadless Pacemakers Market
11.3. Middle East Leadless Pacemakers Market, By Indication
11.3.1. Atrial Fibrillation
11.3.2. High Degree Atrioventricular Block
11.3.3. Sinus node dysfunction
11.4. Middle East Leadless Pacemakers Market, By Technology
11.4.1. Micra Transcatheter Pacing System
11.4.2. Nanostim Leadless Pacemakers
11.4.3. Wireless Cardiac Simulation System
11.5. Middle East Leadless Pacemakers Market, By End User
11.5.1. Hospitals
11.5.2. Catheterization Laboratories
11.6. Middle East Leadless Pacemakers Market Attractiveness Index
11.6.1. By Country
11.6.2. By Indication
11.6.3. By Technology
11.6.4. By End User
12. Africa Leadless Pacemakers Market, By Region
12.1. Introduction
12.1.1. Annual Growth Rate Comparison, By Country
12.1.2. BPS Analysis, By Country
12.2. Market (US$Mn) Forecast, By Country
12.2.1. South Africa Leadless Pacemakers Market
12.2.2. Egypt Leadless Pacemakers Market
12.2.3. North Africa Leadless Pacemakers Market
12.2.4. Rest of Africa Leadless Pacemakers Market
12.3. Africa Leadless Pacemakers Market, By Indication
12.3.1. Atrial Fibrillation
12.3.2. High Degree Atrioventricular Block
12.3.3. Sinus node dysfunction
12.4. Africa Leadless Pacemakers Market, By Technology
12.4.1. Micra Transcatheter Pacing System
12.4.2. Nanostim Leadless Pacemakers
12.4.3. Wireless Cardiac Simulation System
12.5. Africa Leadless Pacemakers Market, By End User
12.5.1. Hospitals
12.5.2. Catheterization Laboratories
12.6. Africa Leadless Pacemakers Market Attractiveness Index
12.6.1. By Country
12.6.2. By Indication
12.6.3. By Technology
12.6.4. By End User
13. Recommendation
13.1. Market Strategy
14. Competitive Landscape
14.1. Competition Dashboard
14.2. List and Company Overview of Global Key Players
14.3. Company Profiles
14.3.1. Medtronic
14.3.1.1. Company Overview
14.3.1.2. Financial Overview
14.3.1.3. Product Portfolio
14.3.1.4. Key Developments
14.3.1.5. Business Strategies
14.3.2. St. Jude Medical LLC
14.3.3. Biotronic
14.3.4. Boston Scientific
14.3.5. Edwards Lifesciences
14.3.6. Sorin Group
14.3.7. Vitatron
14.3.8. Lepu Medical
14.3.9. Terumo Corp.
14.3.10. Others
15. Acronyms
Frequently Asked Questions
What is the projected market size & Compound Annual Growth Rate (CAGR) of the market?
The global leadless pacemakers market in 2020 is estimated for more than US$ 31.3 Mn and expected to reach a value of US$ 69.9 Mn by 2028 with a significant CAGR of 10.6%.
What are the key factors driving the growth of market?
The constantly increasing count of patients suffering from cardiovascular ailments and other heart-related problems, particularly arrhythmias, huge upsurge in the geriatric population, sluggish lifestyle of the population with desk-bound jobs and unhealthy diets are the key factors driving the growth of market
What segments are covered in market report?
The leadless pacemakers market is segmented on the basis of indication, technology, end-user, and by region.
What are the key participating players in the market?
Some of the key participating players in the leadless pacemakers market are Medtronic, St. Jude Medical LLC, Biotronic, Boston Scientific, Edwards Lifesciences, Sorin Group, Vitatron, Lepu Medical, and Terumo Corp.
